COMMUNIQUÉS West-GlobeNewswire

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/10/2024 - 22:15

WALTHAM, Mass. and DUBLIN, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to [...]

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/10/2024 - 22:15

CHARLESTOWN, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]

Certara Completes Acquisition of Chemaxon

02/10/2024 - 22:15

The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization. RADNOR, Pa., [...]

BriaCell Therapeutics Announces Closing of $5 Million Offering

02/10/2024 - 22:05

PHILADELPHIA and VANCOUVER, British Columbia, Oct. 02, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

02/10/2024 - 22:05

Company raises $31 million through ATM, bringing cash runway into 2027 New additions to leadership in technical operations, finance and intellectual property prepare Codexis for the next phase of growth REDWOOD CITY, [...]

Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1

02/10/2024 - 22:05

TuHURA has extended their exclusivity and right of first offer pursuant to the terms of the agreement. Kineta and TuHURA are collaborating on the ongoing Phase 1/Phase 2 clinical trial in patients with advance solid [...]

Range Impact Announces Sale of Cannabinoid Drug Development Business

02/10/2024 - 22:05

CLEVELAND, OHIO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a [...]

Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024

02/10/2024 - 22:05

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2024 [...]

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

02/10/2024 - 22:05

Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabine Results from this Phase 2 trial will evaluate NGC-Cap’s safety-efficacy profile and help to define the optimal dosage [...]

Option Care Health to Announce Third Quarter 2024 Financial Results and Host Conference Call

02/10/2024 - 22:05

BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02/10/2024 - 22:01

SAN DIEGO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Cytokinetics to Host Investor & Analyst Day on October 16, 2024

02/10/2024 - 22:00

Company Leadership to Discuss Cardiac Myosin Modulation, Specialty Cardiology Programs and Commercial Launch Preparations SOUTH SAN FRANCISCO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq [...]

ALPHA PRO TECH, LTD. ANNOUNCES $1 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM FOR IMMEDIATE RELEASE

02/10/2024 - 21:30

NOGALES, Ariz., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

MESA LABS DECLARES QUARTERLY DIVIDEND

02/10/2024 - 20:00

LAKEWOOD, Colo., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]

Doheny Eye Institute To Receive Funding from NIH Award Supporting Cerebral Small Vessel Disease Detection

02/10/2024 - 19:47

Yuhua Zhang, Ph.D., Principal Investigator at Doheny Eye Institute and Professor of Ophthalmology at the David Geffen School of Medicine, UCLA, will lead the development of the next generation of advanced retinal [...]

SAFE - Report de l’Assemblée Générale et de la publication des résultats annuels dans l’attente de l’audience d’examen des plans de redressement du 18 octobre 2024

02/10/2024 - 19:30

Report de l’Assemblée Générale et de la publication des résultats annuels dans l’attente de l’audience d’examen des plans de redressement du 18 octobre 2024 Fleurieux-sur-l’Arbresle - France - le 2 octobre 2024 à 19h30 [...]

ARC Fertility Highlights Importance of Menopause Benefits During October Menopause Awareness Month

02/10/2024 - 18:05

CUPERTINO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- As October marks World Menopause Awareness Month , ARC Fertility (ARC), a highly experienced national provider of innovative fertility, family-forming and women’s and [...]

Informations relatives au nombre total de droits de vote et d’actions composant le capital

02/10/2024 - 18:00

al Nantes, le 2 octobre 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), société [...]

Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine

02/10/2024 - 16:24

PRESS RELEASE Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine Provides important validation of the safety and immunogenicity of [...]